---
$id: https://graph.org.ai/products/commodity/51392204
$type: Product
source: UNSPSC
code: "51392204"
title: "Coumazoline"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Coumazoline

**UNSPSC Code**: 51392204
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TR7Y641235. European Medicines Agency schedules Coumazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06815MIG. Coumazoline generally arises in the molecular formula C14H16N2O. The term COUMAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, no. 10 1972, list 12.) COUMAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule coumazoline under HS 29349990 and SITC 51579. As of Q4 2014, COUMAZOLINE remains the US FDA Preferred Term for this commodity. Coumazoline bears US NLM identifiers UMLS ID C0602991 and NCI Concept Code C79706. SMILES: O1C(C(CC2=NCCN2)C2C1CCCC2)CC.

